Directa Plus (GB:DCTA) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Directa Plus, a leading graphene nanoplatelets producer, is facing a crucial vote at the upcoming General Meeting on 27 June 2024, where shareholders will decide on a proposed £6.8 million Fundraise. The company’s Board has issued a stark warning that failure to pass the resolutions could severely impact its growth strategy and financial stability, as alternative emergency funding would likely be on less favorable terms. Shareholders have been urged to vote in favor to ensure the company’s continued development and value generation.
For further insights into GB:DCTA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue